Wird geladen...
Effect of carvedilol on atrial excitation-contraction coupling, Ca(2+) release, and arrhythmogenicity
Carvedilol is an FDA-approved β-blocker commonly used for treatment of high blood pressure, congestive heart failure, and cardiac tachyarrhythmias, including atrial fibrillation. We investigated at the cellular level the mechanisms through which carvedilol interferes with sarcoplasmic reticulum (SR)...
Gespeichert in:
| Veröffentlicht in: | Am J Physiol Heart Circ Physiol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Physiological Society
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395480/ https://ncbi.nlm.nih.gov/pubmed/32275472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00650.2019 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|